期刊文献+

三苯氧胺逆转卵巢癌细胞株多药耐药性的研究 被引量:3

Reversal of Multi-drug Resistance by Tamoxifen in Ovarian Carcinoma Cells
下载PDF
导出
摘要 目的探讨三苯氧胺(TAM)逆转卵巢癌细胞株的耐药性和逆转机制。方法应用ATP-TCA法检测细胞株的耐药性及TAM的逆转效果,应用流式细胞仪检测TAM对罗丹明123(Rh123)在细胞内积聚和外排的影响,应用免疫荧光技术定量测定TAM对P糖蛋白表达的影响。结果TAM能增加阿霉素对耐药株的细胞毒性作用,能增加耐药株细胞内Rh123的积聚,减少其外排,而对P糖蛋白的表达没有影响。结论TAM能部分逆转卵巢癌细胞株的耐药性,其强度与维拉帕米相当,其作用机理是抑制P糖蛋白的功能,而对其表达水平没有影响。 Objective To investigate the reversal effect and carcinoma cell lines with multi-drug resistance(MDR). Methods the mechanism of tamoxifen(TAM) in ovarian by ATP-TCA. The effects of TAM on Rh123 uptake and efflux were TAM on P-gp expression were analyzed quantitatively by immuno- The reversal efficacy of TAM were measured analyzed by flow cytometer. The effects of fluorescence technique. Results TAM could increase the toxicity of adriamycin (ADM) in A2780/ADM, but not in A2780. TAM could increase cellular rhodamine 123(Rh123) accumulation and decrease its efflux, but had no effect on the expression of P-gp. Conclusions TAM can reverse MDR in ovarian carcinoma cell lines partly, and is similar to verapamil(VPL). TAM may act by blocking the function of P-gp and has no effect on the expression of P-gp.
出处 《国际医药卫生导报》 2005年第16期6-8,共3页 International Medicine and Health Guidance News
基金 广州医学院资助项目(广医科字20013号)
关键词 卵巢肿瘤 多药耐药性 三苯氧胺 阿霉索 Ovarian neoplasms Multidurg resistance Tamoxifen Adriamycin
  • 相关文献

参考文献7

  • 1Miedzinska-Maciejewska M, Wcislo G. Mechanism of multidrug resistance of ovarian cancer. Przegl Lek,2002, 59(10):854 ~ 8.
  • 2Petty RD, Sutherland LA, Hunter EM, Cree IA. Comparison of MTT and ATP-based assays for the measurement of viable cell number. Journal of Bioluminescence and Chemiluminescence, 1995, 10:29~34.
  • 3Chen C-J, Chin JE, Ueda K, et al. Internal duplication and homology with bacterial transport proteins in the MDR1(P-glycoprotein) gene from multidrug-resistant human cells. Cell, 1986, 47:381~9.
  • 4J. Kirk, S. Houlbrool, N.S.A. Stuart, I.J. Stratford,et al. Differntial modulation of doxorubicin toxicity to multidrug and intrinsically drug resistant cell lines by anti-oestrogens and their major metabolites.Br. J. Cancer, 1993, 67:1189~1195.
  • 5Francols Hyafil, Catherine Vergely, Pierre Du Vignaud,et al. In vitro and in vivo reversal of multidrug resisrance by GF120918, an Acridonecarboxamide derivative. Cancer Res, 1993, 53, 4595~4602.
  • 6Peter A.W. te Boekhorst, Jan van Kapel, Martijn Schoester. et al. Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC833 in Chinese hamster ovary cells expressing the mdrl phenotype. Cancer Chemother Pharmacol, 1992, 30:238~242.
  • 7杨晓葵,邢辉,高庆蕾,王薇,邬素芳,卢运萍,王世宣,马丁.mdr-1特异性核酶逆转卵巢癌的多药耐药[J].中华肿瘤杂志,2003,25(5):425-428. 被引量:10

二级参考文献5

  • 1Sambrook J Fritsch EF Maniatis T 等主编 金冬雁 黎盂枫 等译.分子克隆 第2版[M].北京:科学出版社,1996.889—890.
  • 2Heike Y, Kasono K, Kunisaki C, et al. Overcoming multi-drug resistance using an intracellular anti-MDR1 sFv. Int J Cancer, 2001,92:115-122.
  • 3Motomura S, Motoji T, Takanashi M, et al. Inhibition of P-glycoprotein and recovery of drug sensitivity of human acute leukemic blast cells by multidrug resistance gene ( mdr1 ) antisense oligonucleotides. Blood,1998,91:3163-3171.
  • 4Otrmichi T, Kool ET. The virtues of self-binding: high sequence specifisity for RNA cleavage by serf-processed hammerhead ribozymes. Nucleic Acids Res, 2000, 28: 776-783.
  • 5Kobayashi H, Takemura Y, Wang FS, et al. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into mulfidrug-resistant human leukemia cells: screening for effective target sites. Int J Cancer,1999,81:944-950.

共引文献9

同被引文献36

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部